46 results
Summary of Recommendations for the Treatment of Aspergillosis - IDSA Guidelines
 - Invasive syndromes of Aspergillus
Recommendations for the Treatment ... Aspergillosis - IDSA ... Aspergillosis #Treatment ... #pharmacology # ... #medications #IDSA
IDSA Aspergillosis Treatment
 • Invasive pulmonary aspergillosis (IPA)
 • CNS aspergillosis
 • Cardiac Aspergillus infection
 •
IDSA Aspergillosis ... Treatment • Invasive ... Aspergillosis #Treatment ... #management #pharmacology ... #IDSA
IDSA Treatment of Necrotizing Infections of the Skin, Fascia, and Muscle
 • Mixed infections
 • Streptococcus
IDSA Treatment of ... fasciitis #Skin #IDSA ... #Treatment #management ... #antibiotics #pharmacology
Parenteral Antimicrobial Treatment of Common Microorganisms Causing Native Vertebral Osteomyelitis - IDSA 
Staphylococci, oxacillin susceptible
Staphylococci, oxacillin
Antimicrobial Treatment ... Osteomyelitis - IDSA ... Osteomyelitis #management #treatment ... #pharmacology # ... idsa
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
Managing warfarin ... INR Warfarin ... management #algorithm #pharmacology ... #treatment #medications ... cardiology #hematology #warfarin
IDSA - Doses of Drugs for Treatment of Adults and Children with Multidrug-Resistant Tuberculosis
Step 1 Levofloxacin,
IDSA - Doses of ... Drugs for Treatment ... MDRTB #management #Treatment ... antimicrobials #pharmacology ... #dosing #idsa #
Warfarin - INR Goals, Initial Dosing and Bridging

Mechanical Mitral Valve Replacement 2.5-3.5 
Other Valve Replacement 2-3
Warfarin - INR Goals ... Replacement 2-3 VTE Treatment ... for appropriate warfarin ... VTE treatment), ... Bridging #Initiation #Pharmacology
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Outpatient Treatment ... fluoroquinolone #IDSA ... #Antibiotics #Treatment ... Management #Guidelines #pharmacology
Initial treatment of renal bone disease and cinacalcet for secondary hyperparathyroidism
Phosphate binders reduce hyperphosphataemia and hyperparathyroidism.
Initial treatment ... the first-line treatments ... #Pharmacology #Pathophysiology
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Perforation) Pathophysiology ... Tx Management (IDSA ... /severe CDI IDSA ... 2021 CDI Treatment ... infectiousdiseases #IDSA